Biohaven’s drug for genetic neurological disease fails late-stage study
The main goal in the Biohaven study measured the change in severity of symptoms among patients who took the drug, troriluzole,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Biohaven
Biohaven and Pfizer announce results of rimegepant trial for acute treatment of migraine
This is the fourth positive phase-III study of rimegepant for the acute treatment of migraine, and the first to be conducted in…